Allergic Conjunctivitis Clinical Trials

146 clinical trials for Allergic Conjunctivitis across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy — RECRUITING · PHASE3
• Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy — RECRUITING · PHASE3
• Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface — RECRUITING
• Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis — RECRUITING · PHASE2
• Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis — RECRUITING · PHASE2
• A RANDOMIZED, PARALLEL, SINGLE-CENTER, DOUBLE-MASKED, VEHICLE-CONTROLLED PHASE II STUDY TO EVALUATE THE ACTIVITY OF NS2 OPHTHALMIC SOLUTION IN SUBJECTS WITH ALLERGIC CONJUNCTIVITIS USING THE CONJUNCTIVAL ALLERGEN PROVOCATION TEST (CAPT) — RECRUITING · PHASE2
• An Open-label, Long-term Study, with AL-4943A Ophthalmic Solution, 0.2% in Patients with Allergic Conjunctivitis — OTHER · PHASE3
• Efficacy and safety of sodium cromolyn eye drops compared with placebo eye drops in patients with a history of allergic conjunctivitis using the Conjunctival Allergen Challenge model. — ACTIVE_NOT_RECRUITING · PHASE2
• Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Paediatric Patients — OTHER · PHASE4
• The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis — COMPLETED · PHASE3
• A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy — COMPLETED · PHASE3
• A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy — COMPLETED · PHASE3
• Tyrosine Allergoid Paediatric and Adult Study — ACTIVE_NOT_RECRUITING
• The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo — COMPLETED · NA
• Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies — COMPLETED · PHASE2
• Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction — COMPLETED · PHASE4
• Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution — COMPLETED · PHASE3
• Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects — NOT_YET_RECRUITING
• A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis — COMPLETED · PHASE1
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis — COMPLETED · PHASE3
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis — COMPLETED · PHASE3
• The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. — COMPLETED · PHASE3
• A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF R5713-5715 TO REDUCE SIGNS AND SYMPTOMS OF ALLERGIC CONJUNCTIVITIS IN PARTICIPANTS WITH BIRCH POLLEN ALLERGY — COMPLETED
• A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults — COMPLETED · PHASE1
• The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis — OTHER · NA
• A Study Of TL-925 For The Treatment of AC — COMPLETED · PHASE2
• Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations — COMPLETED
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. — COMPLETED · PHASE3
• A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis — COMPLETED · PHASE2
• A Study of TL-925 for the Treatment of Allergic Conjunctivitis — OTHER · PHASE2
• Airway Immune Response to Allergens (Use Lay Language Here) — OTHER · PHASE1
• Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis — COMPLETED · PHASE2
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle — COMPLETED · PHASE3
• PMCF Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops" — COMPLETED · NA
• PMCF Study to Evaluate Performance and Safety of "Xanoftal Next" — COMPLETED · NA
• Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis — COMPLETED · PHASE2
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. — COMPLETED · PHASE3
• Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children — COMPLETED · PHASE3
• A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model — COMPLETED · PHASE2
• Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment — COMPLETED · PHASE4
• Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis — COMPLETED · PHASE2
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis — COMPLETED · PHASE4
• Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis — COMPLETED · PHASE2
• A TWO-PART RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY OF THE ANTI-BET V 1 MONOCLONAL ANTIBODIES TO REDUCE ALLERGIC RHINITIS AND CONJUNCTIVITIS SYMPTOMS AND SKIN TEST REACTIVITY UPON EXPOSURE TO BIRCH ALLERGEN" — COMPLETED
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis — COMPLETED · PHASE4
• THE INVIGORATE 2 TRIAL: A SINGLE-CENTER, RANDOMIZED, DOUBLE-MASKED, CROSS-OVER DESIGN, VEHICLE-CONTROLLED, PHASE 3 CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF REPROXALAP OPHTHALMIC SOLUTION (0.25%) COMPARED TO VEHICLE IN OBJECTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS USING THE ENVIRONMENTAL EXPOSURE CHAMBER (EEC) — COMPLETED · PHASE3
• A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis — COMPLETED · PHASE3
• Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis — COMPLETED · PHASE2
• Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study — COMPLETED · PHASE2
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo — COMPLETED · PHASE4

Refine this search